Kinnaert P, Salmon I, Decoster-Gervy C, Vienne A, De Pauw L, Hooghe L, Tielemans C
Département Médico-Chirurgical de Néphrologie, Dialyse et Transplantation, Cliniques Universitaires de Bruxelles, Hôpital Erasme, Brussels, Belgium.
Arch Surg. 2000 Feb;135(2):186-90. doi: 10.1001/archsurg.135.2.186.
Parathyroid glands are normally surrounded (entirely or partially) by fatty tissue. Subcutaneous parathyroid grafts are thus located in a normal environment. Therefore, we postulated that the late results of subcutaneous implantation of parathyroid tissue in uremic patients should be at least as good as those reported for intramuscular grafting. We also challenged the idea that the recurrence rate of renal hyperparathyroidism after surgery depended solely on the type of hyperplasia (diffuse vs nodular) observed in the implanted tissue.
A retrospective study of a series of patients without loss to follow-up.
A university hospital and 9 affiliated dialysis units.
Fifty-nine patients (33 women and 26 men) operated on for renal hyperparathyroidism underwent the resection of at least 4 parathyroid glands followed by presternal subcutaneous implantation of parathyroid tissue. They were followed up for 12 to 130 months (median, 38 months).
Failure of treatment, recurrence of disease, and hypoparathyroidism.
During the study period, 9 patients had to undergo another operation: 2 (3%) for persistent hyperparathyroidism due to a fifth ectopic gland and 7 (12%) for recurrence of hyperparathyroidism resulting from hypertrophy of the subcutaneous grafts. Four patients received a kidney transplant. The prevalence of hypoparathyroidism (intact parathyroid hormone serum level <1.6 pmol/L with a normal or low serum calcium concentration) was 14% (8 of 59 patients), and the curve representing the distribution of intact parathyroid hormone serum concentrations among operated on patients was shifted to the left when compared with the curve of patients who underwent hemodialysis and who had no indication for parathyroid surgery. In this latter group, the peak of the curve was situated between 1 and 2 times the upper normal limit, while it was in the normal range 12 to 130 months after total parathyroidectomy and subcutaneous parathyroid autotransplantation. No relation was observed between the recurrence rate of the disease and the histological characteristics of the parathyroid grafts. Also, their function was not influenced by the presence or absence of aluminum deposits in bone biopsy specimens that were obtained at the time of cervical exploration.
The late results of total parathyroidectomy and presternal subcutaneous grafting compare favorably with the published data on other surgical techniques proposed for the treatment of renal hyperparathyroidism. The ease with which the hypertrophied grafts are removed when the disease recurs warrants further use of this procedure.
甲状旁腺通常(全部或部分)被脂肪组织包围。因此,皮下甲状旁腺移植位于正常环境中。所以,我们推测尿毒症患者皮下植入甲状旁腺组织的远期效果应至少与肌肉内移植的报道效果一样好。我们还对术后肾性甲状旁腺功能亢进的复发率仅取决于植入组织中观察到的增生类型(弥漫性与结节性)这一观点提出了质疑。
对一系列无失访患者的回顾性研究。
一家大学医院及9个附属透析单位。
59例接受肾性甲状旁腺功能亢进手术的患者(33例女性和26例男性),至少切除4个甲状旁腺,然后将甲状旁腺组织植入胸骨前皮下。对他们进行了12至130个月(中位时间为38个月)的随访。
治疗失败、疾病复发和甲状旁腺功能减退。
在研究期间,9例患者不得不再次手术:2例(3%)因第五个异位甲状旁腺导致持续性甲状旁腺功能亢进,7例(12%)因皮下移植组织肥大导致甲状旁腺功能亢进复发。4例患者接受了肾移植。甲状旁腺功能减退(血清完整甲状旁腺激素水平<1.6 pmol/L且血清钙浓度正常或偏低)的发生率为14%(59例患者中的8例),与接受血液透析且无甲状旁腺手术指征的患者曲线相比,接受手术患者的血清完整甲状旁腺激素浓度分布曲线向左偏移。在后一组中,曲线峰值位于正常上限的1至2倍之间,而在甲状旁腺全切和皮下甲状旁腺自体移植术后12至130个月,该曲线处于正常范围内。未观察到疾病复发率与甲状旁腺移植的组织学特征之间存在关联。此外,在颈部探查时获取的骨活检标本中是否存在铝沉积对其功能没有影响。
甲状旁腺全切和胸骨前皮下移植的远期效果与已发表的用于治疗肾性甲状旁腺功能亢进的其他手术技术的数据相比具有优势。疾病复发时肥大移植组织易于切除这一点值得进一步采用该手术方法。